Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001864317-23-000001)

Filing Details

Accession Number:: 0001864317-23-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-26 18:01:28
Reporting Period:: 2023-09-26

Accepted Time:: 2023-09-26 18:01:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1677077	Alzamend Neuro Inc.	ALZN	Pharmaceutical Preparations (2834)	811822909

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1864317	J David Katzoff	940 South Coast Drive Suite 200 Costa Mesa CA 92626	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-26	53,000	$0.19	81,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.